BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment
- 1 November 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (11) , 1359-1363
- https://doi.org/10.1038/modpathol.3800198
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapyHead & Neck, 2003
- BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTCOncogene, 2003
- Anaplastic thyroid cancerCurrent Opinion in Oncology, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancerGenes, Chromosomes and Cancer, 2002
- Ras Activation of the Raf Kinase: Tyrosine Kinase Recruitment of the MAP Kinase CascadeRecent Progress in Hormone Research, 2001
- Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.Journal of Clinical Investigation, 1993
- High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.Journal of Clinical Investigation, 1993
- p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid CarcinomasJapanese Journal of Cancer Research, 1992
- Loss of genes on the short arm of chromosome 11 in bladder cancerNature, 1985